| Home | Contact us | Search
 

One off donation
Regular donation


Kidney Cancer in the 2010 UK Election News >>

NICE reject Bevacizumab, sorafenib and temsirolimus >>

Press archive - 2009 >>

Press archive - 2010 >>

Press archive - 2008 >>

Press archive - 2007 >>

Press archive - 2006 >>


James Whale Fund for Kidney Cancer welcomes NICE approval of drug in the fight against kidney cancer >>
24 December 2010


The James Whale Fund for Kidney Cancer - Curry & A Quiz Final Quarter 2010 >>
20 October 2010


The James Whale Fund for Kidney Cancer Cardiff Half Marathon Team 2010 >>
17 October 2010


Pazopanib (proprietary name Votrient) >>
14 October 2010


Cancer: the revolution has begun >>
2 October 2010


First conference of The International Kidney Cancer Coalition gives voice to national patient groups >>
27 September 2010


Charity launches first renal cancer nurse training programme >>
24 September 2010


Wellesbourne Calendar Girls bare all for the James Whale Fund >>
23 September 2010


62-mile ride for kidney research! >>
22 September 2010


The Cancer Reform Strategy >>
3 August 2010


Launch of Britain's Biggest Curry Party >>
24 June 2010


Riding from Arch to Arc in aid of kidney cancer >>
24 June 2010


James Whale, Founder & Chairman of the UK's leading klidney cancer charity welcomes The Kidney Cancer Association to British shores! >>
13 April 2010


Response to Conservative Party news on availability of cancer drugs >>
4 April 2010


Drug proved to prolong kidney cancer patients' lives deemed too expensive by NICE >>
9 February 2010


NICE consults on preliminary decision not to recommend everolimus for advanced renal cell carcinoma >>
9 February 2010


Novartis Oncology concerned by initial NICE decision to deny advanced kidney cancer patients effective treatment with Afinitor® (everolimus) >>
9 February 2010


Cancer care plans could cut costs >>
27 January 2010


Technology Appraisal at NICE - EVEROLIMUS ( AFINITOR) - by Bill Savage >>
13 January 2010


News articles relating to N.I.C.E. decision to deny Afinitor >>
9 February 2010


Cancer care plans could cut costs

Health Service Journal, 20 January 2010

http://www.hsj.co.uk/5010531.article

Primary care trusts could make significant cost savings by adopting a more personalised approach to the follow-up care of cancer patients, national clinical director for cancer Professor Mike Richards has said.

Speaking to HSJ ahead of this week’s launch of the National Cancer Survivorship Initiative, Professor Richards said shifting the focus of aftercare for cancer patients towards supported self-management could help reduce the number hospital attendances and unnecessary hospital admissions.

The number of cancer survivors is increasing by three per cent every year and if we don’t do this the costs to the NHS will go up

“If more patients take command of their illness because they’ve been given the proper information and education, this will reduce the risk of them having to come in and out of hospital,” he said.

“Having properly assessed people and planned their care we will be able to give them much more tailored support, including follow-up by telephone. This is good for patients in that they don’t have to go to the hospital all the time and it’s good for the NHS in that it can be very effective and is a lot less expensive,” he added.

The government has invested £1.6m in the cancer survivorship initiative, which was announced in the cancer reform strategy in 2007. Macmillan Cancer Support are currently running 38 pilot studies across England looking at a range of new models of follow-up care for people with different types of cancer.

Professor Richards said the results from the pilot sites will provide information on the costs and benefits of the survivorship initiative.

“At the moment we don’t have good data on the costs of survivorship care as opposed to the costs of primary treatment. The results from the pilot sites will give us something much firmer to go to commissioners with,” he said.

“We want to be engaging with commissioners now saying that this is the direction of travel we are taking. The number of cancer survivors is increasing by three per cent every year and if we don’t do this the costs to the NHS will go up,” he added.

The results from the pilot sites are expected by the end of 2010. The Department of Health will publish a set of principles for service commissioners based on the tested models of care that can be adopted across the NHS.

Share |
The Careline operates 7 days a week
This guide was updated in Feb 2011. It is FREE for patients and clinics to download, or order printed copies.